Page last updated: 2024-10-25

clebopride and Neoplasms

clebopride has been researched along with Neoplasms in 1 studies

clebopride: antidopaminergic; RN given refers to parent cpd; structure

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Clebopride was started at a dosage of 0."2.67A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients. ( Bleiberg, H; Lips, S; N'Koua Mbon, JB; Panzer, JM; Piccart, M, 1992)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bleiberg, H1
Piccart, M1
Lips, S1
Panzer, JM1
N'Koua Mbon, JB1

Trials

1 trial available for clebopride and Neoplasms

ArticleYear
A phase I trial of a new antiemetic drug--clebopride malate--in cisplatin-treated patients.
    Annals of oncology : official journal of the European Society for Medical Oncology, 1992, Volume: 3, Issue:2

    Topics: Adolescent; Adult; Aged; Antiemetics; Antineoplastic Combined Chemotherapy Protocols; Benzamides; Ci

1992